\-\ Texto\\:\\ \ \(0\)\
\-\ none\\ required\ \(5\)\
\-\ \\â\\€\\¢\\ patient\\ 1\\:\\ scleral\\ plaques\\ and\\ phthisis\\ bulbi\\ \\(\\"wood\\ eye\\"\\)\ \(0\)\
\-\ \\Â\\»\\ axial\\ nect\\ shows\\ calcified\\ scleral\\ plaques\\ in\\ the\\ left\\ globe\\ at\\ the\\ insertion\\ sites\\ of\\ the\\ medial\\ and\\ lateral\\ rectus\\ muscles\\.\\ the\\ right\\ globe\\ is\\ calcified\\ and\\ shrunken\\,\\ indicative\\ of\\ phthisis\\ bulbi\\.\ \(0\)\
\-\ \\â\\€\\¢\\ patients\\ 2\\ and\\ 3\\:\\ optic\\ drusen\ \(0\)\
\-\ \\Â\\»\\ axial\\ nect\\ shows\\ a\\ punctate\\ calcification\\ near\\ the\\ optic\\ discs\\.\ \(0\)\
\-\ benign\\ orbital\\ calcifications\ \(0\)\
\-\ \\â\\€\\¢\\ benign\\ globe\\ calcification\ \(0\)\
\-\ \\â\\€\\¢\\ retinoblastoma\ \(1\)\
\-\ \\â\\€\\¢\\ radiation\\ therapy\\ \\(e\\.g\\.\\ for\\ pituitary\\,\\ other\\ skull\\ base\\ tumor\\)\ \(0\)\
\-\ \\â\\€\\¢\\ retinal\\ astrocytic\\ hamartoma\\ \\(tuberous\\ sclerosis\\)\ \(0\)\
\-\ \\â\\€\\¢\\ toxocara\\ canii\\ or\\ other\\ parasitic\\ infection\ \(0\)\
\-\ patient\\ 1\\:\\ 72\\ year\\ old\\ man\\ with\\ remote\\ history\\ of\\ right\\ zygomatic\\ arch\\ fracture\\ and\\ chronic\\ blindness\\.\ \(0\)\
\-\ patients\\ 2\\ and\\ 3\\:\\ 24\\ and\\ 32\\ year\\ old\\ patients\\ with\\ concern\\ for\\ papilledema\\ and\\ visual\\ field\\ deficits\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ globe\\:\\ 0\\.0993074164451288\ \(0\)\
\-\ phthisis\\:\\ 0\\.09608107348709864\ \(0\)\
\-\ bulbi\\:\\ 0\\.09608107348709864\ \(0\)\
\-\ nect\\:\\ 0\\.09365011939651258\ \(0\)\
\-\ scleral\\:\\ 0\\.08334092088673282\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.07312733640780811\ \(0\)\
\-\ plaques\\:\\ 0\\.06363289541509265\ \(0\)\
\-\ \\Â\\»\\:\\ 0\\.05613797650637876\ \(0\)\
\-\ canii\\:\\ 0\\.05414914162271035\ \(0\)\
\-\ optic\\:\\ 0\\.05274274692806435\ \(0\)\
\-\ toxocara\\:\\ 0\\.04952816041897739\ \(0\)\
\-\ calcified\\:\\ 0\\.04890698596204061\ \(0\)\
\-\ shrunken\\:\\ 0\\.04804053674354932\ \(0\)\
\-\ astrocytic\\:\\ 0\\.04804053674354932\ \(0\)\
\-\ wood\\:\\ 0\\.04682505969825629\ \(0\)\
\-\ drusen\\:\\ 0\\.04682505969825629\ \(0\)\
\-\ patients\\:\\ 0\\.044231491987320515\ \(0\)\
\-\ zygomatic\\:\\ 0\\.04278415434112085\ \(0\)\
\-\ calcification\\:\\ 0\\.04135714157942839\ \(0\)\
\-\ blindness\\:\\ 0\\.040716454819095256\ \(0\)\
\-\ benign\\:\\ 0\\.03932067156044269\ \(0\)\
\-\ retinoblastoma\\:\\ 0\\.03914052963200039\ \(0\)\
\-\ discs\\:\\ 0\\.03847330657495383\ \(0\)\
\-\ retinal\\:\\ 0\\.03816317313738789\ \(0\)\
\-\ papilledema\\:\\ 0\\.03546007241666679\ \(0\)\
\-\ parasitic\\:\\ 0\\.03526105266233558\ \(0\)\
\-\ punctate\\:\\ 0\\.03324584684984936\ \(0\)\
\-\ rectus\\:\\ 0\\.03296211608705739\ \(0\)\
\-\ remote\\:\\ 0\\.03296211608705739\ \(0\)\
\-\ indicative\\:\\ 0\\.03255795194161448\ \(0\)\
\-\ axial\\:\\ 0\\.03251721968090496\ \(0\)\
\-\ 72\\:\\ 0\\.03230151006942918\ \(0\)\
\-\ tuberous\\:\\ 0\\.03136429706528791\ \(0\)\
\-\ shows\\:\\ 0\\.03132498266305172\ \(0\)\
\-\ hamartoma\\:\\ 0\\.031149224650499775\ \(0\)\
\-\ sites\\:\\ 0\\.031044235604045508\ \(0\)\
\-\ insertion\\:\\ 0\\.030839091212933815\ \(0\)\
\-\ e\\.g\\:\\ 0\\.03016705988545405\ \(0\)\
\-\ \\:\\:\\ 0\\.03014066175975107\ \(0\)\
\-\ field\\:\\ 0\\.029231344167487894\ \(0\)\
\-\ pituitary\\:\\ 0\\.02855279287208828\ \(0\)\
\-\ 32\\:\\ 0\\.028410943549106386\ \(0\)\
\-\ concern\\:\\ 0\\.028341134883324418\ \(0\)\
\-\ 1\\:\\ 0\\.02711101823946276\ \(0\)\
\-\ orbital\\:\\ 0\\.027022296594458282\ \(0\)\
\-\ 3\\:\\ 0\\.026679673689420532\ \(0\)\
\-\ other\\:\\ 0\\.02626184731603265\ \(0\)\
\-\ deficits\\:\\ 0\\.026068290970187126\ \(0\)\
\-\ muscles\\:\\ 0\\.026019090254869644\ \(0\)\
\-\ visual\\:\\ 0\\.025825840009047963\ \(0\)\
\-\ arch\\:\\ 0\\.02563803416260332\ \(0\)\
\-\ near\\:\\ 0\\.024650164076998292\ \(0\)\
\-\ 2\\:\\ 0\\.02453472662014062\ \(0\)\
\-\ skull\\:\\ 0\\.024262457942617794\ \(0\)\
\-\ eye\\:\\ 0\\.023896065380746078\ \(0\)\
\-\ base\\:\\ 0\\.022316388552209115\ \(0\)\
\-\ 24\\:\\ 0\\.022149713204173\ \(0\)\
\-\ calcifications\\:\\ 0\\.021181091697551686\ \(0\)\
\-\ required\\:\\ 0\\.020504836745248427\ \(0\)\
\-\ sclerosis\\:\\ 0\\.020462101556175633\ \(0\)\
\-\ radiation\\:\\ 0\\.018695008330415576\ \(0\)\
\-\ medial\\:\\ 0\\.018221996757267014\ \(0\)\
\-\ infection\\:\\ 0\\.016560110493818714\ \(0\)\
\-\ chronic\\:\\ 0\\.016046597552713333\ \(0\)\
\-\ therapy\\:\\ 0\\.015230938641604087\ \(0\)\
\-\ fracture\\:\\ 0\\.015020495535151859\ \(0\)\
\-\ \\(\\:\\ 0\\.014447234524877211\ \(0\)\
\-\ \\)\\:\\ 0\\.014270753842266101\ \(0\)\
\-\ none\\:\\ 0\\.014131463379386712\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.014000900250878781\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.013731663346548286\ \(0\)\
\-\ man\\:\\ 0\\.013472878953933329\ \(0\)\
\-\ tumor\\:\\ 0\\.013281548677405408\ \(0\)\
\-\ year\\:\\ 0\\.012748070256972197\ \(0\)\
\-\ lateral\\:\\ 0\\.01231112030416367\ \(0\)\
\-\ right\\:\\ 0\\.012021756121472223\ \(0\)\
\-\ old\\:\\ 0\\.011665794624830063\ \(0\)\
\-\ patient\\:\\ 0\\.011421225745551841\ \(0\)\
\-\ for\\:\\ 0\\.009721441981902869\ \(0\)\
\-\ and\\:\\ 0\\.009600480305718318\ \(0\)\
\-\ history\\:\\ 0\\.007868096918047223\ \(0\)\
\-\ at\\:\\ 0\\.007718421018877554\ \(0\)\
\-\ or\\:\\ 0\\.006676818326424717\ \(0\)\
\-\ left\\:\\ 0\\.006374035128486099\ \(0\)\
\-\ the\\:\\ 0\\.00460830949012086\ \(0\)\
\-\ is\\:\\ 0\\.0037486051892315045\ \(0\)\
\-\ \\,\\:\\ 0\\.0036094675402304987\ \(0\)\
\-\ in\\:\\ 0\\.0028093148676016995\ \(0\)\
\-\ a\\:\\ 0\\.0026439986787906754\ \(0\)\
\-\ of\\:\\ 0\\.0023300760159597686\ \(0\)\
\-\ with\\:\\ 0\\.00156005568119853\ \(0\)\
\-\ \\.\\:\\ 0\\.001419981443893851\ \(0\)\
